criterion_id,criterion_category,criterion_name,stage,program_id,program_name,criterion_type,description,regulatory_basis,applicable_entities,measurement_approach,threshold_percentage,core_requirement,optional_requirement,clinical_objective,administrative_objective,interoperability_objective,ehr_functionality_required,data_elements_involved,implementation_timeline,documentation_requirements,reporting_requirements,compliance_verification,audit_procedures,success_metrics,failure_consequences,related_measures,priority_level,status
MU1-CPOE,Clinical Functionality,Computerized Provider Order Entry,Stage 1,EHR-MEDICARE,Medicare EHR Incentive Program,Core Measure,Implement and use computerized provider order entry (CPOE) for medication orders; CPOE must be integrated with EHR system; includes verification of all medication orders entered electronically; drug interaction checks performed at order entry; orders must be transmitted electronically to pharmacy; supports reduction in medication errors and adverse drug events; enables real-time clinical decision support,HITECH Section 3001; 45 CFR 170.302; 42 CFR 412.24 (Hospital Quality Reporting); CMS Meaningful Use Definition Rule,Hospitals; Critical Access Hospitals (CAHs); Eligible Professionals (EPs); Group practices; Healthcare systems; Clinics,Percentage of medication orders entered through CPOE divided by total medication orders; Medication order submission logs; EHR system audit trails; Pharmacy connectivity verification; Drug interaction check documentation,>=60% of medication orders (Stage 1); >=70% (Stage 2); >=80% (Stage 3),Yes - Core measure for all providers,No - required in all stages,Reduce medication errors; Improve medication safety; Decrease adverse drug events; Enable clinical decision support at point of order,Establish CPOE governance; Implement staff training; Maintain system documentation; Monitor CPOE utilization; Track error reduction,Electronic transmission to pharmacies; Standardized medication order format; Interoperable drug databases; Lab result integration for medication safety,CPOE module; Drug interaction checking engine; Pharmacy connectivity; Order management system; Clinical decision support integration; Audit logging; Role-based access control,Medication names; Dose; Route; Frequency; Indication; Drug allergies; Existing medications; Drug-drug interactions; Lab values relevant to medication; Prescriber identification; Timestamp,2011 Q1-Q2 for initial deployment; 2011 Q3-Q4 for stage 1 compliance; Continuous optimization 2012,CPOE implementation plan; Workflow documentation; Staff training records (all clinical staff); System configuration specifications; Drug database update logs; Pharmacy connectivity test results; CPOE performance metrics; Error rate documentation; Clinical outcome data,Quarterly meaningful use reporting; Monthly CPOE utilization percentages; Medication error tracking; Drug interaction alert effectiveness; Pharmacy connectivity test results; Staff competency assessments,CMS/State audit of CPOE functionality; Verification of medication order percentages; Review of workflow processes; Pharmacy system connectivity testing; Clinical staff interviews; Patient chart audits (sample of medication orders); Medication error analysis,Targeted audits for CPOE implementation; Random chart audits (50-100 charts); System functionality testing; Workflow observation; Staff competency verification; Comparative analysis with peer organizations; Drug interaction alert testing,CPOE adoption rate; Medication order volume via CPOE; Medication error reduction percentage; Adverse drug event reduction; Pharmacy transmission success rate; Staff competency scores; Patient safety improvements; Clinical decision support utilization,Non-compliance: Loss of incentive payment; Negative payment adjustment beginning 2015; Potential loss of recognition in quality programs; Audit findings; Possible state health department investigation; Loss of meaningful use attestation,MU1-Drug Interaction Checking; MU2-CPOE; MU3-CPOE; Promoting Interoperability CPOE measures; Hospital Quality Reporting System measures,Critical,Active
MU1-E-PRESCRIBE,Clinical Functionality,Electronic Prescribing,Stage 1,EHR-MEDICARE,Medicare EHR Incentive Program,Core Measure,Issue at least one electronic prescription (e-prescription) for eligible medications; prescriptions transmitted electronically to pharmacy; includes capability to check for drug interactions; supports medication adherence through electronic transmission; reduces prescription errors and illegible prescriptions; enables pharmacy verification; part of meaningful use safety objectives,HITECH Section 3001; 45 CFR 170.302; Electronic Prescriptions for Controlled Substances (EPCS) Rule; CMS Meaningful Use Definition Rule; DEA regulation 21 CFR 1300-1312,Eligible Professionals (EPs); Dentists; Optometrists; Pediatricians; Family medicine practitioners; Internists; Group practices; Healthcare systems; Pharmacies (recipients),Percentage of prescriptions issued electronically divided by total prescriptions issued; Prescription transmission logs; Pharmacy delivery confirmation; E-prescription platform documentation; Controlled substance prescription handling,>=40% of prescriptions (Stage 1); >=50% (Stage 2); >=60% (Stage 3),Yes - Core measure for EPs and dentists,No - part of core requirements,Reduce prescription errors; Improve patient medication safety; Ensure legible prescriptions; Support medication adherence; Enable real-time pharmacy communication; Reduce prescription fraud,Establish e-prescribing workflow; Implement staff training on e-prescribing; Maintain system configuration; Monitor compliance rates; Document controlled substance procedures; Handle non-e-prescribable medications (controlled substances initially excluded),Standardized prescription format; Pharmacy integration; Controlled substance e-prescription capability; Prescription transmission verification; Pharmacy acknowledgment; Real-time insurance verification; Drug formulary checking,E-prescribing module; Pharmacy connectivity; Prescription transmission system; Controlled substance management (if applicable); Pharmacy network integration; Digital signature capability (for controlled substances); Audit logging,Medication name; Dose; Route; Frequency; Quantity; Refills; Patient demographics; Prescriber information; Pharmacy information; Drug allergy alerts; Insurance information; Timestamp; Authorization codes (for controlled substances),2011 Q1-Q2 for e-prescribing platform selection; 2011 Q3-Q4 for stage 1 implementation; 2012+ for controlled substance e-prescribing,E-prescribing system configuration; Pharmacy partnership agreements; Staff training materials and records; Prescription transmission test results; Workflow documentation; Controlled substance procedure documentation; Compliance tracking methodology,Monthly e-prescription submission percentage; Pharmacy transmission success rate; Non-e-prescribable medication tracking; Staff competency assessments; Patient feedback on e-prescriptions; Prescription error rate tracking; Insurance verification success rate,CMS/State audit of e-prescribing capability; Verification of prescription percentages; Pharmacy connectivity testing; Workflow process review; Staff interviews; Patient chart audits (sample of prescriptions); Controlled substance documentation review; Error analysis,Targeted audits of high e-prescribing providers; Random chart audits (100+ prescriptions); Pharmacy transmission testing; Workflow observation; Staff competency verification; Non-e-prescribable medication tracking; Controlled substance compliance verification,E-prescription adoption rate; Prescription transmission volume; Prescription error reduction; Patient medication adherence improvement; Pharmacy transmission success rate; Controlled substance compliance; Staff competency; Insurance verification success,Non-compliance: Loss of incentive eligibility; Negative payment adjustment; Audit findings; Potential state health department investigation; Loss of meaningful use certification; Risk of DEA enforcement (if controlled substances mishandled),MU1-Drug Interaction Checking; MU2-E-Prescribe; MU3-E-Prescribe; Hospital Quality Reporting (for facilities); Promoting Interoperability e-prescribing measures,Critical,Active
MU1-LAB-INTEGRATION,Clinical Data Management,Lab Result Integration,Stage 1,EHR-MEDICARE,Medicare EHR Incentive Program,Core Measure,Receive and incorporate lab results into EHR; lab results must be viewable in structured format; must include test name; test result; reference range; unit of measure; date result received; ordering provider information; includes capability to view lab data over time; supports clinical decision-making; facilitates identification of abnormal results,HITECH Section 3001; 45 CFR 170.302; CMS Meaningful Use Definition Rule; Laboratory Standards of Care (CLIA regulations); Continuity of Care Document (CCD) Standards,Hospitals; Critical Access Hospitals; Eligible Professionals; Healthcare systems; Group practices; Laboratories (as data sources); EHR vendors,Percentage of patients with lab results incorporated into EHR divided by total unique patients seen in reporting period; Lab result receipt logs; EHR documentation showing lab result viewing; Electronic result transmission records; Data integrity verification,>=40% of unique patients with lab results (Stage 1); >=50% (Stage 2); >=80% (Stage 3),Yes - Core measure,No - required in all stages,Enable clinical decision-making based on lab data; Facilitate disease monitoring; Improve clinical outcomes; Support diagnosis and treatment decisions; Reduce duplicate testing; Enable comparative analysis of results over time,Establish laboratory partnerships; Configure EHR to receive lab results; Implement staff training on lab data interpretation; Maintain system documentation; Track lab result incorporation rates; Verify lab data quality; Implement data validation procedures,Structured lab data exchange; Standardized lab terminology (LOINC codes); Lab result format standards; Real-time or near-real-time transmission; Exception handling for abnormal results; Audit trails for lab data access,Lab result receiving module; HL7 v2/FHIR interface for lab data; Lab result viewing and graphing tools; Abnormal result flags; Historical trending functionality; Data validation algorithms; Audit logging,Test name (LOINC code); Test result value; Reference range; Unit of measure; Date result received; Lab name and ID; Ordering provider; Patient demographics; Specimen information; Timestamp,2011 Q1-Q2 for lab connectivity planning; 2011 Q3-Q4 for stage 1 lab integration; Ongoing lab partnership expansion,Lab integration plan and timelines; Laboratory partnership agreements; EHR configuration specifications; Staff training documentation; HL7/FHIR interface specifications; Lab data quality procedures; Data validation scripts; Error handling documentation,Quarterly lab result receipt percentage; Monthly volume of incorporated lab results; Data accuracy and completeness metrics; Lab result viewing frequency; User adoption statistics; Exception handling effectiveness,CMS/State audit of lab result capability; Verification of patient percentages with lab data; Lab connectivity testing; Review of lab data quality; Staff interviews on lab data utilization; Patient chart audits (100+ charts); Historical trend verification; Data validation testing,Targeted audits of lab integration effectiveness; Random chart audits with lab result focus; Lab connectivity and data quality testing; Staff workflow observation; Data validation sample testing; Comparative analysis of lab data quality across labs; Exception handling review,Lab result incorporation rate; Lab data accuracy; Lab viewing utilization rate; Clinical decision-making frequency based on lab data; Duplicate test reduction; Efficiency in diagnosis; Patient outcome improvements; Data quality scores,Non-compliance: Loss of incentive payment; Negative payment adjustment; Lab partnership impact on patient care; Audit findings; Potential state health department investigation; Loss of meaningful use certification; Risk of lab compliance issues,MU2-Lab Integration; MU3-Lab Integration; Hospital Quality Reporting lab measures; Promoting Interoperability lab data measures,High,Active
MU1-VITALS-RECORDING,Clinical Data Capture,Vital Signs and BMI Recording,Stage 1,EHR-MEDICARE,Medicare EHR Incentive Program,Core Measure,Record vital signs (blood pressure; heart rate; respiratory rate; temperature; oxygen saturation) and body mass index (BMI) for at least one office visit; vital signs and BMI must be documented in structured data fields; includes automated calculation of BMI from height and weight; vital signs must include date and time of measurement; supports identification of abnormal values; enables trending over time; critical for patient safety and chronic disease management,HITECH Section 3001; 45 CFR 170.302; CMS Meaningful Use Definition Rule; Clinical quality standards for vital signs documentation,Hospitals; Critical Access Hospitals; Eligible Professionals; Group practices; Healthcare systems; Clinics; Ambulatory surgery centers,Percentage of office visits with documented vital signs and BMI divided by total office visits; Vital signs documentation logs; BMI calculation verification; EHR audit trails showing vital signs entry; Staff training documentation,>=80% of office visits with vital signs documented (Stage 1); >=90% (Stage 2); >=100% (Stage 3),Yes - Core measure,No - required in all stages,Identify abnormal vital signs promptly; Support chronic disease monitoring; Enable early detection of health issues; Improve patient safety; Support clinical decision-making; Enable population health monitoring,Implement vital signs workflow in EHR; Train clinical staff on vital signs measurement and documentation; Establish structured data entry fields; Implement automated BMI calculation; Monitor compliance rates; Verify data accuracy; Implement quality checks,Structured vital signs data; Automated BMI calculation; Alert generation for abnormal values; Trending functionality; Point-of-care vital signs device integration; Mobile vital signs entry; Real-time alerts to clinicians,Vital signs documentation module; Point-of-care device interfaces; Automated BMI calculator; Alert system for abnormal ranges; Trending and graphing tools; Mobile/tablet vital signs entry; Data validation rules; Audit logging,Systolic blood pressure; Diastolic blood pressure; Heart rate (beats per minute); Respiratory rate (breaths per minute); Body temperature (Celsius/Fahrenheit); Oxygen saturation percentage; Height (inches/cm); Weight (pounds/kg); BMI (calculated); Measurement timestamp; Clinician name,2011 Q1-Q2 for EHR workflow design; 2011 Q3-Q4 for stage 1 documentation; Continuous monitoring,Vital signs EHR workflow documentation; Staff training curriculum and records; Structured data entry field specifications; Point-of-care device integration guidelines; BMI calculation algorithm; Alert threshold configuration; Data quality procedures; Compliance monitoring methodology,Quarterly vital signs documentation percentage; Monthly volume of visits with vital signs recorded; BMI documentation rate; Abnormal alert effectiveness; Staff competency assessments; Data accuracy verification; Trending functionality utilization,CMS/State audit of vital signs documentation; Verification of office visit percentages; Review of vital signs completeness and accuracy; Patient chart audits (100+ visits); Point-of-care device testing; Staff competency verification; Alert system testing; BMI calculation accuracy testing,Targeted audits of providers with low vital signs documentation; Random chart audits with vital signs focus; Data accuracy and completeness testing; Point-of-care device functionality review; Staff workflow observation; Alert system effectiveness assessment; Trending functionality verification,Vital signs documentation rate; BMI documentation rate; Data accuracy percentage; Abnormal alert response rate; Clinical action taken on abnormal values; Staff competency; Patient safety outcomes; Chronic disease control improvements,Non-compliance: Loss of incentive payment; Potential patient safety impact from missed abnormal values; Audit findings; Negative payment adjustment; Loss of meaningful use certification; Risk of quality score reduction; Patient safety liability,MU2-Vitals; MU3-Vitals; Hospital Quality Reporting vital signs measures; Promoting Interoperability vital signs measures; PQRS quality measures,High,Active
MU1-SMOKING-STATUS,Clinical Data Capture,Smoking Status Recording,Stage 1,EHR-MEDICARE,Medicare EHR Incentive Program,Core Measure,Record smoking status for all patients ages 13 and older at each office visit; smoking status must be documented in structured EHR data field; categories include: current smoker; former smoker; never smoker; unknown status; supports identification of smokers for intervention; critical for preventive health; enables population health analyses; supports chronic disease management in smokers; facilitates smoking cessation counseling,HITECH Section 3001; 45 CFR 170.302; CMS Meaningful Use Definition Rule; Healthy People 2020 smoking cessation objectives; USPSTF smoking cessation recommendations,Hospitals; Critical Access Hospitals; Eligible Professionals; Group practices; Healthcare systems; Clinics; Pediatric practices (if serving patients 13+),Percentage of patients ages 13 and older with documented smoking status divided by total patients ages 13+ seen in reporting period; Smoking status documentation logs; EHR audit trails; Staff training records,>=80% of patients 13+ with smoking status documented (Stage 1); >=90% (Stage 2); >=100% (Stage 3),Yes - Core measure,No - required in all stages,Identify smokers for intervention and counseling; Support smoking cessation programs; Improve chronic disease management; Reduce smoking-related complications; Enable population health monitoring of smoking prevalence; Support preventive health initiatives,Implement smoking status workflow in EHR; Train clinical staff on smoking status assessment; Create structured data entry fields; Establish patient age verification (13+); Monitor compliance rates; Implement data quality checks,Structured smoking status data; Age-appropriate screening; Alert generation for smokers; Documentation of smoking cessation counseling offered; Linkage to smoking cessation resources; Population health analytics capability; Real-time reporting,Smoking status documentation module; Age verification algorithm; Structured dropdown/checkbox for smoking status categories; Alert system for smokers; Counseling documentation module; Smoking cessation resource links; Trending and analytics tools; Audit logging,Smoking status category (current/former/never/unknown); Date status recorded; Age of patient (to verify 13+); Clinician name; Timestamp; Smoking cessation counseling offered (Y/N); Counseling method; Cessation resources provided,2011 Q1-Q2 for EHR workflow setup; 2011 Q3-Q4 for stage 1 implementation; Ongoing monitoring,Smoking status workflow documentation; Staff training curriculum and records; Age verification procedure documentation; Structured data field specifications; Alert configuration; Smoking cessation counseling procedures; Data quality processes; Population health analytics setup,Quarterly smoking status documentation percentage; Monthly smoking prevalence statistics; Smoking cessation counseling rates; Staff competency assessments; Data accuracy verification; Alert effectiveness tracking,CMS/State audit of smoking status documentation; Verification of patient percentages; Review of documentation quality; Patient chart audits (100+ charts); Staff competency verification; Smoking cessation counseling tracking; Alert system testing,Targeted audits of low smoking status documentation; Random chart audits with smoking status focus; Data accuracy testing; Staff workflow observation; Patient age verification review; Smoking cessation counseling documentation review; Trend analysis of smoking prevalence,Smoking status documentation rate; Current smoker identification rate; Smoking cessation counseling effectiveness; Population smoking prevalence tracking; Staff competency; Data accuracy; Preventive health improvements,Non-compliance: Loss of incentive payment; Missed opportunity for smoking cessation intervention; Audit findings; Negative payment adjustment; Loss of meaningful use certification; Risk of quality score reduction; Public health impact,MU2-Smoking Status; MU3-Smoking Status; Hospital Quality Reporting preventive measures; Promoting Interoperability preventive health measures; PQRS preventive care measures,High,Active
MU1-MEDICATION-LIST,Clinical Data Capture,Maintain Active Medication List,Stage 1,EHR-MEDICARE,Medicare EHR Incentive Program,Core Measure,Maintain an active medication list for all patients; medication list must include medication name; dose; route; frequency; documented date; indication; allergy interactions; medication list must be updated at each visit; includes OTC medications when known; supports medication safety; prevents adverse drug interactions; enables pharmacist review; critical for patient safety and care coordination,HITECH Section 3001; 45 CFR 170.302; CMS Meaningful Use Definition Rule; Patient Safety Standards; Medication Safety Best Practices,Hospitals; Critical Access Hospitals; Eligible Professionals; Group practices; Healthcare systems; Clinics; Pharmacies (collaborating entities),Percentage of office visits during reporting period where active medication list was documented divided by total office visits; Medication list documentation logs; EHR audit trails; Medication list completeness checks; Update frequency tracking,>=80% of office visits with active medication list documentation (Stage 1); >=90% (Stage 2); >=100% (Stage 3),Yes - Core measure,No - required in all stages,Prevent medication errors; Enable detection of adverse drug interactions; Support medication safety; Facilitate care coordination; Enable pharmacist medication review; Improve patient compliance; Support chronic disease management; Enable emergency medication information access,Implement medication list workflow in EHR; Train clinical staff on medication list maintenance; Establish update procedures at each visit; Implement OTC medication query process; Monitor list completeness; Verify accuracy of medication data; Implement reconciliation procedures,Structured medication list with all required elements; Update at each visit; OTC medication inclusion; Medication-allergy cross-checking; Interaction alerts; Patient-provided medication lists accepted; Third-party medication list integration; Medication reconciliation capability; Real-time updates,Medication list module; Medication database with drug information; Interaction checking engine; Structured medication entry fields; Allergy cross-reference; OTC medication search; Medication reconciliation tools; Alert system; Audit logging,Medication name (generic/brand); Dose (amount and unit); Route (oral/IV/etc); Frequency (timing); Indication (reason for medication); Start date; Status (active/discontinued); Side effects/allergies; Prescriber information; Pharmacy name; Last update timestamp,2011 Q1-Q2 for medication list workflow design; 2011 Q3-Q4 for stage 1 documentation; Ongoing updates at each visit,Medication list workflow documentation; Staff training curriculum and records; Medication database integration; OTC medication process documentation; Medication reconciliation procedures; Allergy cross-check procedures; Data quality standards; Accuracy verification methodology,Quarterly medication list completeness percentage; Monthly documentation frequency; OTC medication inclusion rate; Medication reconciliation frequency; Staff competency assessments; Data accuracy verification; Allergy/interaction detection effectiveness,CMS/State audit of medication list documentation; Verification of visit percentages; Review of list completeness and accuracy; Patient chart audits (100+ visits); Medication reconciliation verification; OTC medication tracking; Allergy cross-check testing; Interaction detection effectiveness,Targeted audits of medication list completeness; Random chart audits with medication focus; Data accuracy and completeness testing; OTC medication inclusion verification; Staff competency assessment; Medication reconciliation process review; Allergy/interaction alert testing,Medication list documentation rate; List completeness percentage; Medication accuracy; OTC medication inclusion; Allergy cross-check effectiveness; Medication reconciliation frequency; Staff competency; Patient safety outcomes; Medication error reduction,Non-compliance: Loss of incentive payment; Increased medication error risk; Patient safety concerns; Audit findings; Negative payment adjustment; Loss of meaningful use certification; Potential patient harm from adverse interactions,MU2-Medication List; MU3-Medication List; Hospital Quality Reporting patient safety measures; Promoting Interoperability medication measures,Critical,Active
MU1-ALLERGY-LIST,Clinical Data Capture,Maintain Active Allergy List,Stage 1,EHR-MEDICARE,Medicare EHR Incentive Program,Core Measure,Maintain an active allergy list for all patients; allergy list must include allergy substance; reaction; severity; onset date; documented status; must be reviewed and updated at each visit; includes medication allergies; food allergies; environmental allergies; contact allergies; no known allergies (NKDA) must be explicitly documented; critical for patient safety; prevents adverse reactions; supports medication safety; enables emergency care coordination,HITECH Section 3001; 45 CFR 170.302; CMS Meaningful Use Definition Rule; Patient Safety and Quality Standards; Medication Safety Best Practices,Hospitals; Critical Access Hospitals; Eligible Professionals; Group practices; Healthcare systems; Clinics; Emergency departments; Specialty practices,Percentage of office visits during reporting period where active allergy list was reviewed and updated divided by total office visits; Allergy list documentation logs; EHR audit trails; NKDA documentation; Allergy severity tracking,>=80% of office visits with active allergy list review and update (Stage 1); >=90% (Stage 2); >=100% (Stage 3),Yes - Core measure,No - required in all stages,Prevent adverse allergy reactions; Enable medication safety (reduce allergy-related medication errors); Support emergency care by providing allergy information; Facilitate specialist consultation with allergy awareness; Improve care coordination; Enable population-level allergy data analysis; Support quality improvement initiatives,Implement allergy list workflow in EHR; Train clinical staff on allergy assessment; Establish review and update procedures at each visit; Implement NKDA documentation; Verify allergy information accuracy; Monitor list completeness; Set up allergy alerts for medications,Structured allergy list with substance name; Reaction type; Severity level (mild/moderate/severe); Onset date; Status (active/resolved/historical); NKDA explicitly documented when applicable; Cross-check with medications at order entry; Alert generation for allergy-medication interactions; Regular updates at each visit,Allergy list module; Allergy database with reaction information; Severity classification system; NKDA documentation field; Medication-allergy interaction checker; Alert system for contraindicated medications; Historical allergy tracking; Cross-reference with pharmacy data; Audit logging,Allergy substance name; Reaction type (rash/anaphylaxis/etc); Severity (mild/moderate/severe); Onset date; Current status; Documentation date; Clinician name; NKDA indicator if applicable; Related medications to avoid,2011 Q1-Q2 for allergy list workflow design; 2011 Q3-Q4 for stage 1 documentation; Ongoing updates at each visit,Allergy list workflow documentation; Staff training curriculum and records; Allergy database integration; NKDA documentation procedure; Medication-allergy interaction procedure; Alert configuration; Data quality standards; Accuracy verification methodology,Quarterly allergy list completeness percentage; Monthly documentation frequency; NKDA documentation rate; Medication-allergy interaction alerts (count/effectiveness); Staff competency assessments; Data accuracy verification; Alert response effectiveness,CMS/State audit of allergy list documentation; Verification of visit percentages; Review of list completeness and accuracy; NKDA documentation verification; Patient chart audits (100+ visits); Medication-allergy interaction testing; Alert system functionality review,Targeted audits of allergy list documentation; Random chart audits with allergy focus; Data accuracy and completeness testing; NKDA documentation verification; Staff competency assessment; Medication-allergy interaction alert testing; Alert response documentation review,Allergy list documentation rate; List completeness percentage; NKDA documentation rate; Medication-allergy interaction alert effectiveness; Staff competency; Patient safety outcomes; Adverse reaction prevention; Emergency care readiness,Non-compliance: Loss of incentive payment; Increased risk of adverse allergy reactions; Patient safety concerns; Potential anaphylaxis risk with medications; Audit findings; Negative payment adjustment; Loss of meaningful use certification; Potential patient harm and liability,MU2-Allergy List; MU3-Allergy List; Hospital Quality Reporting patient safety measures; Promoting Interoperability patient safety measures; Joint Commission patient safety standards,Critical,Active
MU2-CPOE-ADVANCED,Clinical Functionality,Advanced CPOE Implementation,Stage 2,EHR-MEDICARE,Medicare EHR Incentive Program,Core Measure,Expand CPOE implementation beyond medications to include all orders: lab orders; diagnostic imaging orders; procedure orders; referral orders; all orders must include clinical justification; orders must be reviewed with clinical decision support before execution; advanced decision support must provide alerts for patient-specific contraindications; must show efficacy in reducing order errors and improving care quality,HITECH Section 3001; 45 CFR 170.302; CMS Meaningful Use Stage 2 Final Rule; Hospital Quality Reporting systems; Clinical decision support standards,Hospitals; Critical Access Hospitals; Healthcare systems; Group practices with lab and imaging capabilities; Ambulatory surgery centers,Percentage of all orders (medication + lab + imaging + procedure + referral) entered through CPOE; Order entry logs; System audit trails; Decision support logs; Clinical justification documentation,>=60% of all orders (Stage 2); >=80% (Stage 3); Expansion beyond Stage 1 medication orders,Yes - Core measure for Stage 2,No - continuation and expansion of Stage 1,Reduce clinical errors across all order types; Improve clinical decision-making through advanced CDS; Support complex care coordination; Enable real-time verification of order appropriateness; Improve patient safety across all care domains,Expand CPOE governance to include all order types; Implement advanced decision support rules; Train clinical staff on expanded CPOE; Monitor utilization across all order categories; Establish feedback mechanisms; Continuously refine decision support,Expanded order types (all clinical orders); Advanced clinical decision support rules; Patient-specific CDS alerts; Evidence-based order criteria; Real-time contraindication checking; Clinical justification fields; Multi-stage review process; Integration with ancillary systems,Expanded CPOE module; Lab order interface; Imaging order interface; Procedure order interface; Referral order interface; Advanced CDS rule engine; Decision support alert system; Justification documentation module; Multi-level approval workflow; Audit logging,Order type; Order description; Clinical indication; Patient demographics; Relevant test/procedure/referral details; Clinical decision support recommendation; Clinician response to CDS; Override justification (if applicable); Timestamp; Approving clinician,2013 Q1-Q2 for CPOE expansion planning; 2013 Q3-Q4 for advanced CDS implementation; Staged rollout of order types,Expanded CPOE implementation plan; Decision support rule specifications; Staff training curriculum; Lab/Imaging/Procedure system interfaces; CDS alert thresholds; Justification documentation procedures; Data quality standards; Feedback mechanisms,Quarterly expanded CPOE utilization percentages; Monthly volume of orders by type; CDS alert frequency and response rates; Order error reduction tracking; Staff competency assessments; System downtime tracking; Override frequency and justification review,CMS/State audit of expanded CPOE capabilities; Verification of order percentages across all types; CDS rule effectiveness testing; Decision support alert review; Patient chart audits (100+ orders); System interface testing; Staff competency verification; Order error analysis,Targeted audits of expanded CPOE implementation; Random order audits across all types; CDS alert testing and effectiveness; System integration functionality testing; Staff workflow observation; Override justification review; Error analysis; Comparative effectiveness with peer systems,Expanded CPOE adoption rate; All order type utilization percentage; CDS alert response rate; Order error reduction; Clinical decision quality improvements; Care coordination effectiveness; Patient safety outcomes; System reliability,Non-compliance: Loss of Stage 2 incentive payment; Competitive disadvantage vs Stage 2 compliant providers; Negative payment adjustment; Audit findings; Loss of meaningful use certification; Reputational impact; Patient safety concerns,MU3-Advanced CPOE; Promoting Interoperability CPOE measures; Hospital Quality Reporting ordering measures; PQRS quality measures,Critical,Active
MU2-MEDICATION-RECONCILIATION,Clinical Functionality,Medication Reconciliation,Stage 2,EHR-MEDICARE,Medicare EHR Incentive Program,Core Measure,Implement medication reconciliation process at each care transition (admission; discharge; transfer between care settings); medication list must be compared to current medications; discrepancies must be identified and resolved; reconciliation must include active medication list verification; allergy/interaction cross-checking; documentation of any changes made; supports medication safety across care continuum; prevents adverse events at transitions of care,HITECH Section 3001; 45 CFR 170.302; CMS Meaningful Use Stage 2 Final Rule; Joint Commission National Patient Safety Goals; Care Transition Standards,Hospitals; Critical Access Hospitals; Healthcare systems; Specialty practices; Ambulatory surgical centers; Group practices with transfer agreements,Percentage of office visits or care transitions during reporting period where medication reconciliation was documented; Reconciliation documentation logs; EHR audit trails; Medication list comparison records; Discrepancy resolution documentation,>=50% of office visits/transitions with medication reconciliation (Stage 2); >=90% (Stage 3),Yes - Core measure for Stage 2,No - required in Stage 2+,Identify medication discrepancies at care transitions; Prevent medication errors during transitions; Improve medication safety; Resolve therapy conflicts; Enable seamless care coordination; Improve patient outcomes; Support quality improvement; Reduce re-hospitalizations,Implement medication reconciliation workflow; Establish procedures at admission/discharge/transfer points; Train clinical staff on reconciliation process; Document discrepancy resolution; Implement EHR functionality for side-by-side comparison; Monitor compliance; Verify accuracy of reconciliation,Structured reconciliation process; Patient-provided medication list acceptance; Pharmacy cross-check capability; Previous medication list comparison; Current medication verification; Discrepancy identification and resolution; Documentation of changes; Alert for clinically significant discrepancies,Medication reconciliation module; Medication list comparison tools; Patient medication list input field; Pharmacy integration for drug verification; Discrepancy identification algorithm; Alert system; Documentation module; Audit trails; Interoperability interface,Previous medication list; Current medication list (patient); Clinician-verified medication list; Medications added; Medications discontinued; Medications changed; Discrepancy description; Reason for discrepancy; Resolution action taken; Reconciliation timestamp; Reconciling clinician,2013 Q1-Q2 for reconciliation workflow design; 2013 Q3-Q4 for stage 2 implementation; At each transition point,Medication reconciliation workflow documentation; Care transition procedures; Staff training curriculum and records; Pharmacy partnership agreements; EHR functionality specifications; Discrepancy resolution procedures; Quality assurance processes; Documentation templates,Quarterly medication reconciliation completion percentage; Monthly volume of reconciliations performed; Discrepancy identification rate; Resolution effectiveness; Staff competency assessments; Care transition quality metrics,CMS/State audit of reconciliation documentation; Verification of care transition percentages; Review of reconciliation quality and completeness; Patient chart audits (100+ transitions); Pharmacy system cross-checks; Staff competency verification; Discrepancy resolution follow-up,Targeted audits of care transitions; Random chart audits focused on medication reconciliation; Reconciliation quality and completeness testing; Pharmacy data cross-verification; Staff workflow observation; Discrepancy resolution documentation review,Medication reconciliation completion rate; Discrepancy identification effectiveness; Resolution accuracy; Care transition quality; Patient safety outcomes; Re-hospitalization reduction; Staff competency; Care coordination improvements,Non-compliance: Loss of Stage 2 incentive payment; Increased medication error risk at care transitions; Patient safety concerns; Audit findings; Negative payment adjustment; Loss of meaningful use certification; Potential adverse events and liability,MU3-Medication Reconciliation; Promoting Interoperability medication reconciliation; Hospital Quality Reporting safe transitions measures,Critical,Active
MU3-HIE-EXCHANGE,Interoperability & Data Exchange,Health Information Exchange,Stage 3,EHR-MEDICARE,Medicare EHR Incentive Program,Core Measure,Participate in state-mandated or national health information exchange (HIE) networks; exchange clinical summary records with other providers; achieve measurable increases in HIE volume and quality; clinical summaries must include problem list; medication list; allergy list; vital signs; lab results; diagnostic findings; must be exchanged in standards-compliant format; supports care coordination across providers; enables continuity of care; improves quality and efficiency,HITECH Section 3002; 45 CFR 170.302-304; CMS Meaningful Use Stage 3 Final Rule; 42 CFR 412.24 (Hospital Quality Reporting); NHIN standards; State HIE guidelines,Hospitals; Critical Access Hospitals; Healthcare systems; Group practices; Eligible Professionals; Telemedicine providers; Specialists coordinating care,Percentage of office visits where clinical summary for patient was exchanged with other providers; HIE transaction logs; Clinical summary transmission records; Provider acknowledgment documentation; Exchange volume metrics,>=50% of office visits with clinical summary exchange (Stage 3); Increasing trend in HIE volume and quality,Yes - Core measure for Stage 3,No - required for Stage 3+,Enable seamless care coordination; Improve care quality through information sharing; Reduce duplicate testing; Facilitate specialist consultation; Support care transitions; Improve patient outcomes; Enable population health insights; Reduce healthcare costs through efficiency,Participate in state HIE network selection; Establish HIE partnerships; Configure EHR for HIE connectivity; Train staff on HIE processes; Monitor exchange volume and quality; Establish data governance for shared information; Implement security and privacy controls,Certified HIE network participation; Standards-compliant data exchange (FHIR/HL7 v2/CDA); Secure transmission (encryption); Clinical summary with required elements; Provider directory integration; Query and retrieve capability; Patient consent management; Real-time or near real-time exchange,HIE connectivity module; FHIR/HL7 interface; Secure transmission protocol; Clinical summary template; Provider directory integration; Query/retrieve tools; Patient consent management; Data validation; Audit logging; Performance monitoring,Clinical summary content (problems; medications; allergies; vitals; labs; imaging); Patient demographics; Provider identification; Timestamp; Exchange method; Recipient provider; Patient consent status; Data completeness; Quality indicators,2015 Q1-Q2 for HIE network selection and setup; 2015 Q3-Q4 for stage 3 implementation; Ongoing exchange participation,HIE network participation agreement; EHR-HIE connectivity specifications; Staff training curriculum; Data governance policies; Security and privacy procedures; Standards compliance documentation; Quality assurance procedures; Performance monitoring setup,Quarterly HIE exchange volume and percentage; Monthly clinical summary transmissions; Exchange quality metrics; Provider directory accuracy; Patient consent rates; Data completeness verification; System uptime and performance; Staff competency assessments,CMS/State audit of HIE participation; Verification of exchange percentages and volume; Review of clinical summary quality; Data standards compliance verification; Patient chart audits (100+ exchanges); HIE network testing; Security and privacy compliance; Patient consent review,Targeted audits of HIE implementation; Random exchange audits for quality and completeness; Data standards compliance testing; Provider directory accuracy verification; Security and privacy compliance review; Staff competency assessment; Comparative analysis with peer HIE providers,HIE participation rate; Clinical summary exchange volume; Exchange quality percentage; Data completeness; Provider participation; Patient consent rates; Care coordination improvements; Quality outcomes; Cost reduction indicators,Non-compliance: Loss of Stage 3 incentive payment; Exclusion from advanced payment models; Competitive disadvantage; Negative payment adjustment; Loss of quality recognition; Reduced ability to coordinate care; Audit findings; Loss of meaningful use certification,Promoting Interoperability HIE measures; State HIE participation; Federal NHIN connectivity; Care coordination quality measures,Critical,Active
MU3-API-PATIENT-ACCESS,Interoperability & Data Exchange,Patient Access API,Stage 3,EHR-MEDICARE,Medicare EHR Incentive Program,Core Measure,Provide patient access to electronic health information through secure API (Application Programming Interface); patients must be able to download; transmit; or access their complete EHR data; includes problem list; medication list; allergy list; vital signs; lab results; imaging results; clinical notes; patients must be able to use third-party applications to access and manage their health data; must comply with FHIR or other open standards; supports patient autonomy and data portability; enables patient-directed care; supports population health research,HITECH Section 3002; 45 CFR 170.302-304; CMS Meaningful Use Stage 3 Final Rule; 21st Century Cures Act Section 4001 (Information Blocking); 42 CFR 414.1315 (Promoting Interoperability);ONC Patient Access API Rule,All Medicare providers participating in Meaningful Use; Hospitals; Healthcare systems; Group practices; Eligible Professionals; Telemedicine providers; Specialty practices,Percentage of patients with access to their electronic health information through API or secure download; API transaction logs; Patient portal activity logs; Third-party application access logs; Data download records,>=80% of patients offered API access (Stage 3); >=90% (Promoting Interoperability),Yes - Core measure for Stage 3,No - required for Stage 3+,Empower patients with access to their health data; Enable patient participation in care; Support chronic disease self-management; Facilitate patient-provider communication; Enable patient-directed research participation; Reduce health disparities through data access; Support health literacy,Implement patient API functionality; Configure secure authentication; Train staff on API processes; Publicize API availability to patients; Monitor API utilization; Address API issues/errors; Ensure compliance with data security standards,FHIR-compliant API; Secure authentication (OAuth 2.0 or equivalent); Encryption for data in transit; Patient authorization controls; Downloadable data format (PDF/CSV/XML); Third-party app integration; Documentation of API availability; Real-time API access; Performance monitoring,Patient API module; FHIR server; Authentication system (OAuth 2.0); Secure transmission protocol (HTTPS/TLS); Patient portal interface; Data export/download tools; Third-party integration capability; Usage analytics; Security monitoring; Audit logging,All EHR data accessible via API: problem list; medication list; allergy list; vital signs; lab results; imaging results; clinical notes; procedures; immunizations; patient contact information; insurance information; Any modifications to API scope; Timestamp; Patient consent status; API access logs,2015 Q1-Q2 for API development and testing; 2015 Q3-Q4 for stage 3 implementation; Ongoing access provision and support,Patient API architecture and specifications; FHIR standards compliance documentation; Authentication and security procedures; Patient portal integration design; Staff training curriculum; API availability publicity plan; Third-party integration guidelines; Performance and security monitoring; Error handling procedures,Quarterly API availability and performance metrics; Monthly patient API utilization rates; Number of patients accessing via API; Third-party applications used; Data download frequency; API error rates; User satisfaction surveys; Staff competency assessments,CMS/State audit of API functionality; Verification of API availability and performance; FHIR compliance testing; Security and authentication testing; Patient access verification; Third-party integration review; Patient satisfaction assessment; Data protection verification,Targeted audits of API implementation; API functionality and performance testing; FHIR standards compliance verification; Security and authentication testing; Patient access and data accuracy verification; Third-party integration review; Performance monitoring; User experience assessment,API adoption rate; Patient access percentage; API utilization frequency; Third-party integration uptake; Patient satisfaction; Data security incidents (should be minimal); System reliability; User engagement; Patient empowerment indicators,Non-compliance: Loss of Stage 3 incentive payment; Information blocking violation with up to $100,000+ penalties; Exclusion from advanced payment models; Competitive disadvantage; Negative payment adjustment; Loss of quality recognition; Audit findings; Loss of meaningful use certification; Potential OHI OCR investigation,Promoting Interoperability API measures; 21st Century Cures Act Patient Access Rule; State API requirements; Federal NHIN connectivity,Critical,Active